Acquired Toxoplasma gondii infection in the pediatric population from Villa Clara province
Keywords:
toxoplasmosis, toxoplasma gondii, acquired infectionAbstract
Introduction: the toxoplasmosis is a disease, caused by the parasite Toxoplasma gondii; it can be congenital or acquired and it has a wide worldwide distribution.Objective: to describe the characteristics of the infested pediatric patients by Toxoplasma gondii whish were diagnosed at the “José Luis Miranda” Pediatric University Hospital from Villa Clara Province.
Methods: it was made a transversal character descriptive study to a sample of 54 patients which were diagnosed with Toxoplasma gondii infection in the period from January 2014 to December 2016.
Results: 54 patients who were diagnosed, 61.1% belonged to female sex and the 72.2% were from rural zones and they had been in contact with infected animals.
Conclusion: the acute acquired toxoplasmosis in the pediatric population from Villa Clara Province showed a high proportion at its systematic form, with a superiority in adolescents and in females from rural zones, and complications at the diagnosis with the ocular form. It is recommended the development of studies about the parasite – environment – susceptible host interaction that would allow to give answers to the main epidemiologic factors which influence the acquisition of the disease.
Downloads
References
1.Cruz Quevedo M, Hernández Cruz A, Dorta Contreras AJ. El nexo entre biología, respuesta inmune y clínica en la infección por Toxoplasma gondii. Rev Cubana Invest Bioméd [Internet]. 2019 Dic [citado 06/04/2020];38(4):e256. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002019000400014&lng=es
2.Sánchez R, Sánchez L, Miranda A, Camejo L, Araujo L. La toxoplasmosis observada como un problema no resuelto. Rev Cubana Invest Bioméd [Internet]. 2015 [citado 06/04/2020];35(3):272-283. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002016000300006
3.American Academy of Ophthalmology. 2017-2018 Basic and Clinical Science Course (BCSC), Section 09: Intraocular Inflammation and Uveitis [Internet]. San Francisco: American Academy of Ophthalmology; 2017 [citado 02/02/2020]. Disponible en: https://www.aao.org/assets/7ce25010-6aa7-4c39-bf1d-2953f46e8b53/636312522051970000/bcsc1718-s09-pdf
4.Ambou Frutos I, Vilches Lescaille DC, Osorio Illas L. Toxoplasmosis ocular. En: Rio Torres M, Fernández Argones L, Hernández Silva JR, Ramos López M. Oftalmología. Diagnóstico y tratamiento. 2da ed. La Habana: Editorial Ciencias Médicas; 2018.
5.Chacín Bonilla L, Sánchez Chávez Y, Estévez J, Larreal Y, Molero E. Prevalence of human toxoplasmosis in San Carlos Island, Venezuela. INCI [Internet]. 2003 [citado 02/02/2020];28(8):457-462. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0378-18442003000800005
6.Jones JL, Muccioli C, Belfort R, Holland GN, Roberts JM, Silveira C. Recently acquired Toxoplasma gondii infection, Brazil. Emerg Infect Dis [Internet]. 2012 [citado 12/02/2020];12(4):582-587. Disponible en: https://wwwnc.cdc.gov/eid/article/12/4/05-1081_article. https://doi.org/10.3201/eid1204.051081
7.Yates WB, Chiong F, Zagora S, Post JJ, Wakefield D, McCluskey P. Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis. Asia Pac J Ophthalmol (Phila) [Internet]. 2019 [citado 02/02/2020];8(4):280-284. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727929/. https://dx.doi.org/10.1097/APO.0000000000000244
8.Naranjo Valladares BT, León Sánchez MA, Iglesias Rojas MB, Sainz Padrón L. Toxoplasmosis ocular: aspectos clínico-epidemiológicos en edad pediátrica. Rev Cienc Méd [Internet]. 2020 [citado 06/04/2020];24(4):e4457. Disponible en: http://revcmpinar.sld.cu/index.php/publicaciones/article/view/4457
9.Rosales Oliva A, Rosales Oliva M, Mendoza Galán O. Infección por Toxoplasma gondii en un adolescente. MEDISAN [Internet]. 2016 [citado 02/02/2020];20(1):73-76. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192016000100011
10.Samudio M, Acosta ME, Castillo V, Guillén Y, Licitra G, Aria L, et al. Aspectos clínico-epidemiológicos de la toxoplasmosis en pacientes que consultan por problemas de visión. Rev Chil Infectol [Internet]. 2015 [citado 06/04/2017];32(6):658-663. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182015000700007
11.Abbasi Fard S, Khajeh A, Khosravi A, Mirshekar A, Masoumi S, Tabasiet F, et al. Fulminant and Diffuse Cerebral Toxoplasmosis as the First Manifestation of HIV Infection: A Case Presentation and Review of the Literature. Am J Case Rep [Internet]. 2020 [citado 02/02/2020];21:[aprox. 6 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998800/. https://dx.doi.org/10.12659/AJCR.919624
12.Arantes TEF, Silveira C, Holland GN, Muccioli C, Yu F, Jones JL, et al. Ocular involvement following postnatally acquired toxoplasma gondii infection in southern Brazil: A 28-year experience. Am J Ophthalmol. 2015 [citado 02/02/2020];159(6):1002–1012.e2. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25743338/. https://doi.org/10.1016/j.ajo.2015.02.015
13.Rouatbi M, Amairia S, Amdouni Y, Boussaadoun MA, Ayadi O, Taha Al-Hosary AA, et al. Toxoplasma gondii infection and toxoplasmosis in North Africa: a review. Parasite [Internet]. 2019 [citado 12/02/2020];26(6):[aprox. 21 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376878/. https://doi.org/10.1051/parasite/2019006
14.Rubinstein E, Keynan Y. Lymphadenopathy. En: Cohen J, Powderly WG, Opal SM. Infectious Diseases. 4ta ed. New York: Elsevier; 2017. p. 136-145.e1 [citado 12/02/2020]. Disponible en: https://www.sciencedirect.com/science/article/pii/B9780702062858000150. https://doi.org/10.1016/B978-0-7020-6285-8.00015-0
15.Aguirre AA, Longcore T, Barbieri M, Dabritz H, Hill D, Klein PN, et al. The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies. EcoHealth [Internet]. 2019 [citado 15/03/2020];16:378-390. Disponible en: https://link.springer.com/article/10.1007/s10393-019-01405-7
16.Basavaraju A. Toxoplasmosis in HIV infection: An overview. Trop Parasitol [Internet]. 2016 [citado 04/04/2020];6(2):129-135. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048699/. https://dx.doi.org/10.4103/2229-5070.190817
17.Rubio Rodríguez CG, Rodríguez Gil R, Pérez Muñoz D, Kalitovics Nobregas N, Alvarez Reyes F. Toxoplasmosis ocular adquirida en nuestro medio. Revisión de casos. Arch Soc Canar Oftal [Internet]. 2016 [citado 06/04/2020];27:55-62. Disponible en: http://sociedadcanariadeoftalmologia.com/wp-content/revista/revista-27/27sco14.pdf
18.Murata FHA, Previato M, Frederico FB, Pires Barbosa A, Nakashima F, Magela de Faria G, et al. Evaluation of Serological and Molecular Tests Used for the Identification of Toxoplasma gondii Infection in Patients Treated in an Ophthalmology Clinic of a Public Health Service in São Paulo State, Brazil. Front Cell Infect Microbiol [Internet]. 2020 [citado 12/02/2012];9:472. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019025/. https://dx.doi.org/10.3389/fcimb.2019.00472
19.Ginorio Gavito DE, Vilches Lescaille D, Gracial Baralt M, Cox Iraola R, Casanova P, Núñez Fernández P, et al. Toxoplasmosis Ocular. Algunos hallazgos clínicos y seroepidemiológicos. AACC [Internet]. 2017 [citado 12/02/2012];7(3):4-13. Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/352/352
20.Guerrero AC, Gómez J, Samudio M, Bolaños A, Dorantes Y, Scalamogna M, et al. Prevalencia de cicatrices retinocoroideas por Toxoplasma en una población del Paraguay. Mem Inst Investig Cienc Salud [Internet]. 2016 Apr [citado 12/02/2020];14(1):78-85. Disponible en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S1812-95282016000100012. https://doi.org/10.18004/Mem.iics/1812-9528/2016.014(01)78-085
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
October 1 2025
